Markers Umorali Nella Osteodistrofia Uremica

Malluche H.H. , Ritz E. , Lange H.P. Bone histology in incipient and advanced renal failure. Kidney Int 1976; 9: 355–62.

Dahl E. , Nordal K.P. , Attramadal A. , Hase J. , Flatmark A. Renai osteodystrophy in predialysis patients wothout stainable bone aluminum. Acta Med Scand 1988; 224: 157–64.

Mora Palma F.J. , Ellis H.A.S. , Cook D.B. Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Q J Med 1983; 207: 332–48.

Moriniere P. , Cohen Solai M. , Belbrik S. , Sebert J.L. , Fournier A. Disappearance of aluminic bone disease in a long term asynmptomatic dialysis population restricting Al (OH) 3: emergence of an idiopathic adynamic bone disease. Nephron 1989; 56: 93–101.

Carvalho A.B. , Jorgetti Cendoroglo Neto M. , Vieira J.G.H. , Drueke T. , Draibe S.A. , Ajzen H. High incidence of adynamic bone disease (ABD) in chronic renal failure predialysis (CRF) patients. Nephrol Dial Trnasplant 1992; 7: 755.

Evans R.A. , Flynn J. , Dunstan C.R. , George C.R.P. , McDonnell G.D. Bone metabolism in chronic renal failure. Miner Electrolyte Metab 1992; 7: 207–18.

Sherrard D.J. , Ott S. , Malney N. , Andress D. , Coburn J. Renal osteodystrophy: classification, cause and treatment. In: Frame B. , Potts J.T. Jr. eds. Clinical Disorders of Bone and Mineral Metabolism. Amsterdam: Excerpta Medica, 1983; 254–9.

Malluche H.H. , Faugère M.C. Atlas of mineralized bone histology, Basel: Karger, 1986.

Smith A.J. , Faugère M.C. , Abreo K. , Fanti P. , Julian P. , Malluche H.H. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol 1986; 6: 275–83.

Fournier A. , Morinière P. , Cohen Solai M.E. Adynamic bone disease in uremia: may it be idiopathic? Is it an actual disease? Nephron 1991; 58: 1–12.

Coen G. , Mazzaferro S. Bone metabolism and its assessment in renal failure. Nephron 1994; 67: 383–401.

Coen G. , Mazzaferro S. , Bonucci E. Bone GLA protein in predialysis chronic renal failure: effects of 1,25 (OH) 2D3 administration in a long-term follow-up. Kidney Int 1985; 28: 783–90.

Mazzaferro S. , Coen G. , Ballanti P. Osteocalcin, iPTH, alkaline phosphatase and hand x-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy. Nephron 1990; 56: 261–6.

Coen G. , Mazzaferro S. , Ballanti P. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure. J Lab Clin Med 1993; 122: 103–9.

Taubman M.B. , Goldberg B. , Sherr C.J. Radioimmunoassay for human procollagen. Science 1974; 186: 1115–7.

Melkko J. , Niemi S. , Risteli L. , Risteli J. Radioimmunoassay for the carboxyterminal propeptide of human type procollagen. Clin Chem 1990; 36: 1328–32.

Smedrod B. , Melkko J. , Risteli L. , Risteli J. Circulating C-terminal propeptide of type 1 procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J 1990; 271: 345–50.

Partridge N.C. , Dickson C.A. , Kopp K. , Teitelbaum S.L. , Crouch E.C. , Kahn A.J. Parathyroid hormone inhibits collagen synthesis at both ribonucleic acid and protein levels in rat osteogenic sarcoma cells. Mol Endocrinol 1989; 3: 232–9.

Simon L.S. , Slovik D.M. , Neer R.M. , Krane S.M. Changes in serum levels of type I and type III procollagen extension peptides during infusion of human parathyroid hormone fragment (1-34). J Bone Miner Res 1988; 3: 241–6.

Rowe D.W. , Kram B.E. Regulation of collagen synthesis in fetal rat cavaria by 1,25-dihydroxyvitamin D3. J Biol Chem 1982; 257: 8009–15.

Parfitt A.M. , Simon L.S. , Villanueva A.R. , Krane S.M. Procollagen type I carboxyterminal extension peptide in serum as a marker of collagen biosynthesis in bone: correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 1987; 2: 427–36.

Haukipuro K. , Melkko J. , Risteli L. , Kairaluoma M.I. , Risteli J. Connective tissue response to major surgery and postoperative infection. Eur J Clin Invest 1992; 22: 330–40.

Prockop D.J. , Kivirikko K.I. , Tuderman L. , Guzman N.A. The biosynthesis of collagen and its disorders. N Engl J Med 1979; 301: 13–23.

Seibel M.J. , Robins S. , Bilezikian J.P. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992; 3: 263–70.

Risteli J. , Elomaa I. , Niemi S. , Novamo A. , Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type 1 collagne: a new marker of bone collagen degradation. Clin Chem 1993; 39: 635–40.

Coen G. , Mazzaferro S. , Ballanti P. Procollagen type 1 C-terminal extension peptide in predialysis chronic renal failure. Am J Nephrol 1992; 12: 246–51.

Hamdy N.A.T. , Risteli J. , Risteli L. Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis? Neprhol Dial Transplant 1994; 9: 511–6.

Coen G. , Ballanti P. , Mazzaferro S. , Pasquali M. , Bonucci E. Procollagen type 1 c-terminal extension peptide, PTH and 1,25 (OH)2D3 in chronic renal failure. Bone 1993; 14: 415–20.

Gerakis A. , Nicolou Ch , Konstantinidis S. , Apostolou Th , Spantidakis V.I. , Billis A. Is serum procollagen carboxyterminal propetide a useful index for the diagnosis of renal osteodystrophy? Nephrol Dial Transplant 1994; 9: 908.

Coen G. , Mazzaferro S. , DeAntoni E. Procollagen type I C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients. Am J Nephrol 1994; 14: 106–12.

Coen G. , Mazzaferro S. , Chicca S. , Pasquali M. , Sardella D. Decreased bone collagen breakdown and increased osteobalstic procollagen syntehsis after parathyroidectomy. EDTA-ERA Abstracts, September 1993; 217.